avrg: GSE58827: Dynamics of the Mouse Liver
Gene Symbol | Gene ID | Gene Info |
---|---|---|
E2f3
|
ENSMUSG00000016477.11 | E2F transcription factor 3 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
E2f3 | mm10_v2_chr13_-_29984219_29984353 | 0.79 | 8.1e-09 | Click! |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.5 | 7.4 | GO:0045660 | positive regulation of neutrophil differentiation(GO:0045660) |
2.1 | 6.2 | GO:0010751 | negative regulation of nitric oxide mediated signal transduction(GO:0010751) regulation of cGMP-mediated signaling(GO:0010752) |
1.4 | 4.2 | GO:2000371 | regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000371) positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000373) |
1.1 | 5.4 | GO:0034092 | negative regulation of maintenance of sister chromatid cohesion(GO:0034092) negative regulation of maintenance of mitotic sister chromatid cohesion(GO:0034183) maintenance of mitotic sister chromatid cohesion, telomeric(GO:0099403) mitotic sister chromatid cohesion, telomeric(GO:0099404) regulation of maintenance of mitotic sister chromatid cohesion, telomeric(GO:1904907) negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric(GO:1904908) |
1.0 | 3.0 | GO:2000620 | positive regulation of histone H4-K16 acetylation(GO:2000620) |
1.0 | 6.9 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
1.0 | 5.8 | GO:0010166 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.8 | 2.4 | GO:0071963 | establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
0.7 | 2.2 | GO:1901675 | negative regulation of histone H3-K27 acetylation(GO:1901675) |
0.7 | 4.0 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.6 | 2.5 | GO:1900220 | semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
0.6 | 3.0 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
0.6 | 0.6 | GO:0031990 | mRNA export from nucleus in response to heat stress(GO:0031990) |
0.6 | 4.1 | GO:1901552 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.6 | 2.3 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.5 | 3.7 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
0.5 | 4.7 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.5 | 3.4 | GO:0033567 | DNA replication, Okazaki fragment processing(GO:0033567) |
0.5 | 3.7 | GO:0042148 | strand invasion(GO:0042148) |
0.4 | 2.2 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) |
0.4 | 5.8 | GO:0033504 | floor plate development(GO:0033504) |
0.4 | 4.2 | GO:0035879 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.3 | 1.0 | GO:0019085 | early viral transcription(GO:0019085) |
0.3 | 2.3 | GO:0048478 | replication fork protection(GO:0048478) |
0.3 | 4.1 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.3 | 2.5 | GO:0090267 | positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) |
0.3 | 2.1 | GO:0019985 | translesion synthesis(GO:0019985) |
0.3 | 2.4 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
0.3 | 0.8 | GO:0014718 | positive regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014718) myoblast development(GO:0048627) |
0.3 | 3.1 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.3 | 1.6 | GO:1904179 | positive regulation of adipose tissue development(GO:1904179) |
0.3 | 1.6 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.3 | 1.1 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
0.3 | 1.3 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
0.2 | 6.2 | GO:0043486 | histone exchange(GO:0043486) |
0.2 | 2.0 | GO:0044791 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
0.2 | 1.0 | GO:1904049 | negative regulation of spontaneous neurotransmitter secretion(GO:1904049) |
0.2 | 1.5 | GO:0044806 | G-quadruplex DNA unwinding(GO:0044806) |
0.2 | 1.7 | GO:1903691 | positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
0.2 | 3.1 | GO:0060923 | cardiac muscle cell fate commitment(GO:0060923) |
0.2 | 1.2 | GO:1905247 | positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902961) negative regulation of metalloendopeptidase activity(GO:1904684) positive regulation of aspartic-type peptidase activity(GO:1905247) |
0.2 | 1.9 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.2 | 1.6 | GO:0036337 | Fas signaling pathway(GO:0036337) |
0.2 | 2.8 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.2 | 1.8 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
0.2 | 7.8 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.2 | 4.7 | GO:0072520 | seminiferous tubule development(GO:0072520) |
0.2 | 2.3 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.2 | 1.0 | GO:0061511 | centriole elongation(GO:0061511) |
0.2 | 3.0 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
0.2 | 1.6 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.2 | 0.8 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.2 | 1.2 | GO:0051987 | positive regulation of attachment of spindle microtubules to kinetochore(GO:0051987) |
0.2 | 0.8 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.2 | 1.1 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.2 | 0.7 | GO:1901594 | detection of temperature stimulus involved in thermoception(GO:0050960) response to capsazepine(GO:1901594) |
0.2 | 2.8 | GO:0015809 | arginine transport(GO:0015809) |
0.2 | 0.5 | GO:0090204 | protein localization to nuclear pore(GO:0090204) negative regulation of vascular endothelial growth factor production(GO:1904046) |
0.2 | 0.5 | GO:1902299 | pre-replicative complex assembly involved in nuclear cell cycle DNA replication(GO:0006267) pre-replicative complex assembly(GO:0036388) pre-replicative complex assembly involved in cell cycle DNA replication(GO:1902299) |
0.2 | 2.1 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.2 | 0.5 | GO:1902162 | regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) |
0.2 | 1.0 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
0.2 | 1.0 | GO:1901837 | negative regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901837) |
0.2 | 0.8 | GO:0021993 | initiation of neural tube closure(GO:0021993) |
0.2 | 2.7 | GO:0009263 | deoxyribonucleotide biosynthetic process(GO:0009263) |
0.1 | 1.3 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
0.1 | 0.8 | GO:2000973 | regulation of pro-B cell differentiation(GO:2000973) |
0.1 | 0.9 | GO:0016266 | O-glycan processing(GO:0016266) |
0.1 | 1.0 | GO:0015808 | L-alanine transport(GO:0015808) |
0.1 | 0.7 | GO:0072092 | ureteric bud invasion(GO:0072092) |
0.1 | 1.8 | GO:0060211 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
0.1 | 0.4 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.1 | 0.7 | GO:1902969 | mitotic DNA replication(GO:1902969) |
0.1 | 2.2 | GO:0040034 | regulation of development, heterochronic(GO:0040034) |
0.1 | 1.0 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.1 | 0.4 | GO:0060697 | glucosylceramide catabolic process(GO:0006680) positive regulation of phospholipid catabolic process(GO:0060697) |
0.1 | 0.4 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.1 | 0.3 | GO:0099552 | trans-synaptic signaling by lipid, modulating synaptic transmission(GO:0099552) trans-synaptic signaling by endocannabinoid, modulating synaptic transmission(GO:0099553) |
0.1 | 4.8 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.1 | 1.6 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
0.1 | 0.3 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.1 | 0.9 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.1 | 0.4 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
0.1 | 1.7 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.1 | 0.6 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.1 | 0.7 | GO:0036120 | cellular response to platelet-derived growth factor stimulus(GO:0036120) |
0.1 | 1.5 | GO:0071539 | protein localization to centrosome(GO:0071539) |
0.1 | 2.0 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.1 | 0.5 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.1 | 0.8 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.0 | 1.3 | GO:0009251 | glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
0.0 | 0.4 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.0 | 0.5 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.0 | 1.8 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.0 | 0.3 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.0 | 1.1 | GO:1902751 | positive regulation of cell cycle G2/M phase transition(GO:1902751) |
0.0 | 1.1 | GO:1901741 | positive regulation of myoblast fusion(GO:1901741) |
0.0 | 0.2 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
0.0 | 0.4 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.0 | 0.3 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.0 | 0.2 | GO:0042758 | long-chain fatty acid catabolic process(GO:0042758) |
0.0 | 0.1 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
0.0 | 0.9 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.0 | 1.5 | GO:0001755 | neural crest cell migration(GO:0001755) |
0.0 | 1.0 | GO:0033120 | positive regulation of RNA splicing(GO:0033120) |
0.0 | 0.2 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.0 | 2.5 | GO:0016579 | protein deubiquitination(GO:0016579) |
0.0 | 0.8 | GO:0048246 | macrophage chemotaxis(GO:0048246) |
0.0 | 0.9 | GO:0006360 | transcription from RNA polymerase I promoter(GO:0006360) |
0.0 | 1.3 | GO:0048024 | regulation of mRNA splicing, via spliceosome(GO:0048024) |
0.0 | 0.3 | GO:0032274 | gonadotropin secretion(GO:0032274) |
0.0 | 0.4 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.0 | 0.4 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.0 | 0.3 | GO:0034243 | regulation of transcription elongation from RNA polymerase II promoter(GO:0034243) |
0.0 | 0.7 | GO:0010718 | positive regulation of epithelial to mesenchymal transition(GO:0010718) |
0.0 | 0.1 | GO:0015824 | proline transport(GO:0015824) |
0.0 | 0.4 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.0 | 3.3 | GO:0045444 | fat cell differentiation(GO:0045444) |
0.0 | 0.6 | GO:0006779 | porphyrin-containing compound biosynthetic process(GO:0006779) |
0.0 | 0.8 | GO:0035914 | skeletal muscle cell differentiation(GO:0035914) |
0.0 | 0.1 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.0 | 0.1 | GO:0035542 | negative regulation of vesicle fusion(GO:0031339) regulation of SNARE complex assembly(GO:0035542) negative regulation of calcium ion-dependent exocytosis(GO:0045955) |
0.0 | 0.2 | GO:0060033 | anatomical structure regression(GO:0060033) |
0.0 | 1.5 | GO:0007631 | feeding behavior(GO:0007631) |
0.0 | 2.7 | GO:0032496 | response to lipopolysaccharide(GO:0032496) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.4 | 4.2 | GO:0000799 | nuclear condensin complex(GO:0000799) |
1.1 | 4.2 | GO:1990707 | subtelomeric heterochromatin(GO:1990421) nuclear subtelomeric heterochromatin(GO:1990707) |
1.0 | 6.9 | GO:0000796 | condensin complex(GO:0000796) |
0.8 | 4.0 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
0.7 | 0.7 | GO:0000811 | GINS complex(GO:0000811) |
0.7 | 6.2 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.7 | 4.7 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.7 | 7.4 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.5 | 2.7 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.5 | 0.5 | GO:0005656 | nuclear pre-replicative complex(GO:0005656) pre-replicative complex(GO:0036387) |
0.5 | 3.0 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.4 | 4.4 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.4 | 1.2 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
0.4 | 1.5 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.4 | 1.5 | GO:0005610 | laminin-5 complex(GO:0005610) laminin-10 complex(GO:0043259) |
0.4 | 1.8 | GO:0034715 | U7 snRNP(GO:0005683) pICln-Sm protein complex(GO:0034715) |
0.3 | 2.3 | GO:0031298 | replication fork protection complex(GO:0031298) |
0.3 | 2.0 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
0.3 | 1.0 | GO:0035061 | interchromatin granule(GO:0035061) |
0.3 | 2.1 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.2 | 1.5 | GO:0005638 | lamin filament(GO:0005638) |
0.2 | 1.0 | GO:1990761 | growth cone lamellipodium(GO:1990761) |
0.2 | 2.1 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.2 | 0.9 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
0.2 | 1.9 | GO:0071439 | clathrin complex(GO:0071439) |
0.1 | 3.1 | GO:0016580 | Sin3 complex(GO:0016580) |
0.1 | 1.0 | GO:0001740 | Barr body(GO:0001740) |
0.1 | 0.5 | GO:0032021 | NELF complex(GO:0032021) |
0.1 | 4.0 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.1 | 5.2 | GO:0016592 | mediator complex(GO:0016592) |
0.1 | 1.5 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.1 | 1.2 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.1 | 1.3 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.1 | 1.1 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.1 | 1.0 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
0.1 | 2.5 | GO:0034451 | centriolar satellite(GO:0034451) |
0.1 | 3.5 | GO:0002102 | podosome(GO:0002102) |
0.1 | 0.8 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.1 | 0.5 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.1 | 2.3 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.1 | 1.6 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.1 | 1.3 | GO:0001891 | phagocytic cup(GO:0001891) |
0.1 | 4.1 | GO:0072686 | mitotic spindle(GO:0072686) |
0.1 | 5.8 | GO:0005814 | centriole(GO:0005814) |
0.1 | 4.2 | GO:0005776 | autophagosome(GO:0005776) |
0.0 | 0.5 | GO:0045298 | tubulin complex(GO:0045298) |
0.0 | 1.4 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
0.0 | 2.1 | GO:0005871 | kinesin complex(GO:0005871) |
0.0 | 3.6 | GO:0016605 | PML body(GO:0016605) |
0.0 | 0.6 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.0 | 0.4 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.0 | 0.6 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.0 | 3.7 | GO:0000794 | condensed nuclear chromosome(GO:0000794) |
0.0 | 3.0 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.0 | 1.3 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.0 | 1.3 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.0 | 0.7 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
0.0 | 2.3 | GO:0005581 | collagen trimer(GO:0005581) |
0.0 | 1.5 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.0 | 0.2 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.0 | 0.2 | GO:0061574 | ASAP complex(GO:0061574) |
0.0 | 0.2 | GO:0000242 | pericentriolar material(GO:0000242) |
0.0 | 6.2 | GO:0005925 | focal adhesion(GO:0005925) |
0.0 | 0.2 | GO:0042555 | MCM complex(GO:0042555) |
0.0 | 0.8 | GO:0031519 | PcG protein complex(GO:0031519) |
0.0 | 1.7 | GO:0001650 | fibrillar center(GO:0001650) |
0.0 | 0.3 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.5 | 6.2 | GO:0070052 | collagen V binding(GO:0070052) |
1.2 | 5.8 | GO:0080019 | fatty-acyl-CoA reductase (alcohol-forming) activity(GO:0080019) |
0.7 | 4.2 | GO:0044547 | DNA topoisomerase binding(GO:0044547) |
0.6 | 3.1 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.6 | 4.2 | GO:0015616 | DNA translocase activity(GO:0015616) |
0.6 | 1.7 | GO:0004637 | phosphoribosylamine-glycine ligase activity(GO:0004637) |
0.5 | 2.7 | GO:0061731 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.5 | 3.7 | GO:0000150 | recombinase activity(GO:0000150) |
0.5 | 2.0 | GO:0036033 | mediator complex binding(GO:0036033) |
0.4 | 2.5 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.4 | 2.4 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.4 | 3.4 | GO:0003910 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.4 | 2.8 | GO:0015181 | arginine transmembrane transporter activity(GO:0015181) |
0.3 | 1.0 | GO:0005302 | L-tyrosine transmembrane transporter activity(GO:0005302) |
0.3 | 1.3 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.3 | 4.7 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.2 | 1.5 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.2 | 1.6 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.2 | 2.7 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.2 | 7.4 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
0.2 | 4.4 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.2 | 0.8 | GO:0052743 | inositol tetrakisphosphate phosphatase activity(GO:0052743) |
0.2 | 0.8 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.2 | 0.8 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.2 | 1.6 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.2 | 1.1 | GO:0050733 | RS domain binding(GO:0050733) |
0.1 | 0.9 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.1 | 1.3 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.1 | 4.0 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.1 | 0.9 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.1 | 0.4 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.1 | 4.5 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.1 | 0.4 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.1 | 1.0 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.1 | 2.5 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.1 | 0.6 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
0.1 | 0.7 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
0.1 | 1.1 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.1 | 4.8 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.1 | 0.4 | GO:0070976 | TIR domain binding(GO:0070976) |
0.1 | 0.4 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.1 | 0.4 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.1 | 1.2 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.1 | 3.7 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.1 | 0.8 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.1 | 2.1 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.1 | 0.3 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.1 | 1.7 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.1 | 0.9 | GO:0001163 | RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
0.1 | 0.5 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.1 | 0.3 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.1 | 5.2 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.1 | 0.7 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.1 | 0.9 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.1 | 3.0 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.1 | 0.3 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.1 | 0.5 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.1 | 0.3 | GO:0016434 | rRNA (cytosine) methyltransferase activity(GO:0016434) |
0.1 | 5.9 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.1 | 1.8 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.1 | 3.8 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.1 | 2.5 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.1 | 1.1 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.1 | 0.5 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.1 | 0.7 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.0 | 3.4 | GO:0030276 | clathrin binding(GO:0030276) |
0.0 | 0.8 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.0 | 1.1 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
0.0 | 1.2 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.0 | 0.5 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.0 | 1.5 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.0 | 3.2 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.0 | 1.6 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
0.0 | 2.0 | GO:0003727 | single-stranded RNA binding(GO:0003727) |
0.0 | 0.5 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.0 | 5.0 | GO:0042393 | histone binding(GO:0042393) |
0.0 | 0.3 | GO:0034595 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) phosphatidylinositol phosphate 5-phosphatase activity(GO:0034595) |
0.0 | 5.0 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
0.0 | 1.3 | GO:0019843 | rRNA binding(GO:0019843) |
0.0 | 0.5 | GO:0030332 | cyclin binding(GO:0030332) |
0.0 | 1.4 | GO:0015485 | cholesterol binding(GO:0015485) |
0.0 | 0.1 | GO:0004452 | isopentenyl-diphosphate delta-isomerase activity(GO:0004452) |
0.0 | 0.4 | GO:0070330 | aromatase activity(GO:0070330) |
0.0 | 3.7 | GO:0008022 | protein C-terminus binding(GO:0008022) |
0.0 | 0.4 | GO:0008373 | sialyltransferase activity(GO:0008373) |
0.0 | 0.1 | GO:0045545 | syndecan binding(GO:0045545) |
0.0 | 0.1 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 14.6 | PID ATM PATHWAY | ATM pathway |
0.2 | 11.1 | PID AURORA B PATHWAY | Aurora B signaling |
0.2 | 1.6 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.2 | 5.3 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.1 | 5.6 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.1 | 1.5 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.1 | 7.1 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.1 | 1.6 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.1 | 1.0 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.1 | 2.7 | PID ATR PATHWAY | ATR signaling pathway |
0.1 | 2.2 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.1 | 2.6 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.1 | 2.0 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.1 | 4.3 | PID E2F PATHWAY | E2F transcription factor network |
0.0 | 1.2 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.0 | 0.7 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.0 | 2.0 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.0 | 1.8 | PID REELIN PATHWAY | Reelin signaling pathway |
0.0 | 1.3 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.0 | 0.7 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.0 | 1.5 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.0 | 0.4 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.0 | 0.7 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.0 | 1.5 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.0 | 2.1 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.0 | 1.1 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.0 | 0.3 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.0 | 0.5 | PID SHP2 PATHWAY | SHP2 signaling |
0.0 | 3.0 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.8 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 11.6 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.3 | 4.0 | REACTOME REPAIR SYNTHESIS FOR GAP FILLING BY DNA POL IN TC NER | Genes involved in Repair synthesis for gap-filling by DNA polymerase in TC-NER |
0.2 | 0.2 | REACTOME AUTODEGRADATION OF THE E3 UBIQUITIN LIGASE COP1 | Genes involved in Autodegradation of the E3 ubiquitin ligase COP1 |
0.2 | 4.3 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.2 | 5.5 | REACTOME KINESINS | Genes involved in Kinesins |
0.2 | 5.8 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.2 | 4.4 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.1 | 1.8 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.1 | 7.0 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.1 | 0.7 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.1 | 1.6 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.1 | 2.5 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.1 | 1.1 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.1 | 7.6 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.1 | 2.5 | REACTOME TRANSPORT OF RIBONUCLEOPROTEINS INTO THE HOST NUCLEUS | Genes involved in Transport of Ribonucleoproteins into the Host Nucleus |
0.1 | 0.5 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
0.1 | 1.9 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.1 | 3.9 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.1 | 2.2 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.1 | 0.9 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.1 | 0.5 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.1 | 2.9 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.1 | 1.3 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.1 | 2.1 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.1 | 2.3 | REACTOME MRNA 3 END PROCESSING | Genes involved in mRNA 3'-end processing |
0.1 | 1.6 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
0.1 | 2.6 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.1 | 5.3 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.0 | 0.5 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.0 | 2.0 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.0 | 0.9 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.0 | 0.5 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.0 | 0.4 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.0 | 2.8 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.0 | 1.8 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.0 | 1.5 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.0 | 0.9 | REACTOME FRS2 MEDIATED CASCADE | Genes involved in FRS2-mediated cascade |
0.0 | 1.4 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.0 | 0.4 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.0 | 0.4 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.0 | 1.2 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.0 | 0.4 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.0 | 0.5 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.0 | 0.3 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.0 | 0.9 | REACTOME TRANSLATION | Genes involved in Translation |